mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |